bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Generate Biomedicines Inc. logo

    Generate Biomedicines Inc.

    GENB | NASDAQ
    Chart Builder DCF Calculator
    $13.42
    -$1.04 (-7.19%)
    Nov 2, 2026, 1:38 PM ET · Market open

    Market Data

    Market Cap
    $1.72B
    Enterprise Value
    $1.46B
    Beta
    -0.14
    Average Volume
    1.08M
    Shares Outstanding (Diluted)
    128.24M
    Shares Change YoY
    N/A
    Institutional Ownership
    78.19%
    Exchange
    NASDAQ
    ISIN
    US3709201004

    Price Performance

    Price Change 1M
    -2.0%
    Price Change 3M
    -6.4%
    Price Change 6M
    -7.2%
    Price Change YTD
    N/A
    Price Change 1Y
    N/A
    Price Change 3Y
    N/A
    Price Change 5Y
    N/A
    1M CAGR (ann.)
    -15.6%
    1Y CAGR (ann.)
    N/A
    5Y CAGR (ann.)
    N/A
    All-Time CAGR
    22.1%

    Valuation

    PE Ratio
    -13.64
    Forward PE
    N/A
    PEG Ratio
    -0.09
    Forward PEG
    0.12
    PS Ratio
    137.09
    Forward PS
    77.90
    PB Ratio
    4.07
    P/FCF Ratio
    -12.97
    P/Adj. FCF Ratio
    -12.27
    P/OCF Ratio
    -9.90
    EV/Sales
    107.93
    EV/EBIT
    -11.14
    EV/EBITDA
    -11.72
    EV/FCF
    -10.21
    Earnings Yield
    -7.3%
    FCF Yield
    -7.7%
    Adj. FCF Yield
    -8.2%

    Financial Health

    Net Cash
    $457.42M
    Total Debt
    $62.63M
    Cash & Short-Term Investments
    $457.42M
    Total Assets
    $561.69M
    Current Ratio
    8.30
    Quick Ratio
    8.30
    Debt / Equity Ratio
    0.14
    Debt / EBITDA
    -0.50
    Debt / FCF
    -0.44
    OCF / Debt
    -2.21
    Interest Coverage
    -304.16
    Altman Z-Score
    8.67
    Piotroski F-Score
    0

    Margins & Profitability

    Gross Profit Margin
    86.2%
    Operating Profit Margin
    -1002.6%
    EBITDA Margin
    -750.9%
    Net Profit Margin
    -765.3%
    FCF Margin
    -1056.6%
    Adj. FCF Margin
    -1117.5%
    SBC / Revenue
    58.0%
    SBC Impact (per share)
    -5.8%

    Returns

    Return on Assets
    -32.3%
    Return on Equity
    -153.1%
    Return on Invested Capital
    -37.8%
    Return on Capital Employed
    -38.8%
    Return on Tangible Assets
    -32.3%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    2
    EPS Growth Next 3Y
    -60.4%
    Revenue Growth Next 3Y
    18.4%
    Earnings Date
    Nov 5, 2026
    EPS Estimate (next Q)
    -$0.51
    EPS Growth Est (next Q)
    N/A
    Revenue Est (next Q)
    $7.75M
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $26.00
    Price Target Upside
    79.8%

    Cash Flow

    Operating Cash Flow
    $-138.33M
    Free Cash Flow
    $-143.05M
    Adj. Free Cash Flow
    $-151.28M
    FCF Per Share
    -$1.50
    OCF Per Share
    -$1.46
    OCF/S Ratio
    -790.5%

    Income Statement

    Revenue
    $13.54M
    Gross Profit
    $10.27M
    Operating Income
    $-135.73M
    EBITDA
    $-124.66M
    Net Income
    $-128.7M
    EPS (Diluted)
    -$1.06
    Revenue / Employee
    $43.39K
    Profit / Employee
    $-412.5K
    Employees
    312

    © 2026 bestshares.com. All rights reserved.

    All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.